semaglutide patent expiry date Massive Rs 50,000 Cr Opportunity for Drugmakers as Patents Expire, ETPharma Canada approves generic semaglutide from

Compounded GLP-1 drugs from licensed 503A pharmacies contain the same active peptide as brand-name versions and must meet FDA safety and sterility standards

These shifts in glutamate pools could be achieved without increasing oxidative stress or cell death

Primary Research Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling

As obesity and insulin resistance are closely tied, this mechanism addresses root causes rather than symptomsmaking it especially valuable for patients with metabolic syndrome or prediabetes